{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:50:51Z","timestamp":1793235051143,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2875-13-228","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T09:06:49Z","timestamp":1402391209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mirincamycin, an old candidate for malaria combination treatment and prophylaxis in the 21st century: in vitro interaction profiles with potential partner drugs in continuous culture and field isolates"],"prefix":"10.1186","volume":"13","author":[{"given":"Peter","family":"Starzengruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Fuehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashidul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasif A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Graninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Noedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"3256_CR1","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM: Artemisinin resistance in Cambodia 1 (ARC1) study consortium: evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008, 359: 2619-2620. 10.1056\/NEJMc0805011.","journal-title":"N Engl J Med"},{"key":"3256_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1073\/pnas.1211205110","volume":"110","author":"S Takala-Harrison","year":"2013","unstructured":"Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, Fukuda MM, Nosten F, Noedl H, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Socheat D, Ariey F, Phyo AP, Starzengruber P, Fuehrer HP, Swoboda P, Stepniewska K, Flegg J, Arze C, Cerqueira GC, Silva JC, Ricklefs SM, Porcella SF, Stephens RM, Adams M: Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A. 2013, 110: 240-245. 10.1073\/pnas.1211205110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3256_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4269\/ajtmh.1969.18.485","volume":"18","author":"KG Powers","year":"1969","unstructured":"Powers KG: Activity of chlorinated lincomycin analogues against Plasmodium cynomolgi in rhesus monkeys. Am J Trop Med Hyg. 1969, 18: 485-490.","journal-title":"Am J Trop Med Hyg"},{"key":"3256_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.1970.19.1","volume":"19","author":"LH Schmidt","year":"1970","unstructured":"Schmidt LH, Harrison J, Ellison R, Worcester P: The activities of chlorinated lincomycin derivatives against infections with Plasmodium cynomolgi in Macaca mulatta. Am J Trop Med Hyg. 1970, 19: 1-11.","journal-title":"Am J Trop Med Hyg"},{"key":"3256_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1128\/AAC.27.2.151","volume":"27","author":"LH Schmidt","year":"1985","unstructured":"Schmidt LH: Enhancement of the curative activity of primaquine by concomitant administration of mirincamycin. Antimicrob Agents Chemother. 1985, 27: 151-157. 10.1128\/AAC.27.2.151.","journal-title":"Antimicrob Agents Chemother"},{"key":"3256_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1128\/AAC.01090-09","volume":"54","author":"J Held","year":"2010","unstructured":"Held J, Westerman R, Kremsner PG, Mordm\u00fcller B: In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon. Antimicrob Agents Chemother. 2010, 54: 540-542. 10.1128\/AAC.01090-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"3256_CR7","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/AAC.00527-07","volume":"51","author":"EL Dahl","year":"2007","unstructured":"Dahl EL, Rosenthal PJ: Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob Agents Chemother. 2007, 51: 3485-3490. 10.1128\/AAC.00527-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"3256_CR8","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1128\/AAC.00312-09","volume":"53","author":"P Starzengruber","year":"2009","unstructured":"Starzengruber P, Thriemer K, Haque R, Khan WA, Fuehrer HP, Siedl A, Hofecker V, Ley B, Wernsdorfer WH, Noedl H: Antimalarial activity of tigecycline, a novel glycylcycline antibiotic. Antimicrob Agents Chemother. 2009, 53: 4040-4042. 10.1128\/AAC.00312-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"3256_CR9","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1128\/AAC.01619-10","volume":"55","author":"P Khemawoot","year":"2011","unstructured":"Khemawoot P, Saunders D, Rasameesoraj M, Melendez V, Imerbsin R, Ohrt C, Fracisco S, Teja-Isavadharm P: Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum. Antimicrob Agents Chemother. 2011, 55: 5881-5886. 10.1128\/AAC.01619-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"3256_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4269\/ajtmh.2004.71.711","volume":"71","author":"H Noedl","year":"2004","unstructured":"Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS: A histidine-rich protein 2-based malaria drug sensitivity assay for field use. Am J Trop Med Hyg. 2004, 71: 711-714.","journal-title":"Am J Trop Med Hyg"},{"key":"3256_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/AAC.01023-06","volume":"51","author":"H Noedl","year":"2007","unstructured":"Noedl H, Krudsood S, Leowattana W, Tangpukdee N, Thanachartwet W, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Yingyuen K, Sriwichai S, Ohrt C, Knirsch C: In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob Agents Chemother. 2007, 51: 651-656. 10.1128\/AAC.01023-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"3256_CR12","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00436-011-2763-z","volume":"110","author":"D Ganesh","year":"2012","unstructured":"Ganesh D, Fuehrer HP, Starzengr\u00fcber P, Swoboda P, Khan WA, Reismann JA, Mueller MS, Chiba P, Noedl H: Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones. Parasitol Res. 2012, 110: 2289-2295. 10.1007\/s00436-011-2763-z.","journal-title":"Parasitol Res"},{"key":"3256_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","volume":"137","author":"MC Berenbaum","year":"1978","unstructured":"Berenbaum MC: A method for testing for synergy with any number of agents. J Infect Dis. 1978, 137: 122-130. 10.1093\/infdis\/137.2.122.","journal-title":"J Infect Dis"},{"key":"3256_CR14","unstructured":"World Health Organization: In vitro test (mark II) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine\/pyrimethamine and amodiaquine. [http:\/\/www.who.int\/malaria\/publications\/atoz\/markiii.pdf]"},{"key":"3256_CR15","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1128\/AAC.47.11.3494-3499.2003","volume":"47","author":"M Ramharter","year":"2003","unstructured":"Ramharter M, Noedl H, Winkler H, Graninger W, Wernsdorfer WH, Kremsner PG, Winkler S: In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum. Antimicrob Agents Chemother. 2003, 47: 3494-3499. 10.1128\/AAC.47.11.3494-3499.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"3256_CR16","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1086\/430309","volume":"40","author":"M Ramharter","year":"2005","unstructured":"Ramharter M, Oyakhirome S, Klein Klouwenberg P, Ad\u00e9gnika AA, Agnandji ST, Missinou MA, Matsi\u00e9gui PB, Mordm\u00fcller B, Borrmann S, Kun JF, Lell B, Krishna S, Graninger W, Issifou S, Kremsner PG: Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis. 2005, 40: 1777-1784. 10.1086\/430309.","journal-title":"Clin Infect Dis"},{"key":"3256_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pt.2013.03.012","volume":"29","author":"F Noulin","year":"2013","unstructured":"Noulin F, Borlon C, Van Den Abbeele J, D'Alessandro U, Erhart : 1912\u20132012: a century of research on Plasmodium vivax in vitro culture. Trends Parasitol. 2013, 29: 286-294. 10.1016\/j.pt.2013.03.012.","journal-title":"Trends Parasitol"},{"key":"3256_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","volume":"383","author":"A Llanos-Cuentas","year":"2014","unstructured":"Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, M\u00f6hrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L: Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014, 383: 1049-1058. 10.1016\/S0140-6736(13)62568-4.","journal-title":"Lancet"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-13-228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:05:07Z","timestamp":1630555507000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-13-228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3256"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-13-228","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]},"assertion":[{"value":"28 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"228"}}